The expression levels of HSPB2 and HSPB3 molecular chaperone genes in BlCa patients are significantly deregulated, being thus able to distinguish malignant (at different stages) specimens from adjacent normal bladder tissues. Here, HSPB3 is linked to bladder transitional cell carcinoma.